Table 3.
The efficiency of the antibodies effective against Omicron and its sub-variants.
| Sl. No. | Therapeutic Antibodies | Neutralization Efficacy in Different Omicron Sub-Variants | ||||
|---|---|---|---|---|---|---|
| BA.1 | BA.2 | BA.3 | BA.4 | BA.5 | ||
| 1. | Tixagevimab | Low | Low | Low | Low | Low |
| 2. | Bamlanivimab | Low | Low | Low | Low | Low |
| 3. | Imdevimab | Low | Moderate | Low | Moderate | Moderate |
| 4. | Regdanvimab | Low | Low | - | - | - |
| 5. | Sotrovimab | Moderate | Moderate | Moderate | Moderate | Moderate |
| 6. | Casirivimab | Low | Low | Low | Low | Low |
| 7. | Cilgavimab | Low | High | High | High | High |
| 8. | Etesevimab | Low | Low | Low | Low | Low |
| 9. | Bebtelovimab | High | High | High | High | High |
| 10. | Bamlanivimab + Etesevimab | Low | Low | Low | Low | Low |